GrapMJ, MunroCL, WetzelPA, BestAM, KetchumJM, HamiltonVA, et al. Sedation in adults receiving mechanical ventilation: physiological and comfort outcomes. Am J Crit Care, 2012; 21(3):e53-e63; quiz-e64.
2.
DevlinJW, SkrobikY, GélinasC, NeedhamDM, SlooterAJC, PandharipandePP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med, 2018; 46(9):e825-e873.
3.
HerridgeMS, CheungAM, TanseyCM, Matte-MartynA, Diaz-GranadosN, Al-SaidiF, et al. Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med, 2003; 348(8):683-693.
4.
CheungAM, TanseyCM, TomlinsonG, Diaz-GranadosN, MattéA, BarrA, et al. Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med, 2006; 174(5):538-544.
5.
ElyEW, ShintaniA, TrumanB, SperoffT, GordonSM, HarrellFE, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA, 2004; 291(14):1753-1762.
6.
ShehabiY, ChanL, KadimanS, AliasA, IsmailWN, TanMATI, et al. Sedation Practice in Intensive Care Evaluation (SPICE) Study Group investigators. Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multi-center cohort study. Intensive Care Med, 2013; 39(5):910-918.
7.
PunBT, BadenesR, HerasLa, CalleG, OrunOM, ChenW, RamanR, et al. COVID-19 Intensive Care International Study Group. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multi-center cohort study. Lancet Respir Med, 2021; 9(3):239-250.
8.
WongtangmanK, SanterP, WachtendorfLJ, AzimaraghiO, Baedorf KassisE, TejaB, et al. SICU Optimal Mobilization Team (SOMT) Group. Association of sedation, coma, and in-hospital mortality in mechanically ventilated patients with coronavirus disease 2019–related acute respiratory distress syndrome: a retrospective cohort study. Crit Care Med, 2021; 49(9):1524-1534.
9.
BalasMC, BurkeWJ, GannonD, CohenMZ, ColburnL, BevilC, et al. Implementing the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle into everyday care: opportunities, challenges, and lessons learned for implementing the ICU pain, agitation, and delirium guidelines. Crit Care Med, 2013; 41(9 Suppl 1):S116-127.
10.
StollingsJL, DevlinJW, LinJC, PunBT, ByrumD, BarrJ, et al. Best practices for conducting interprofessional team rounds to facilitate performance of the ICU liberation (ABCDEF) bundle. Crit Care Med, 2020; 48(4):562-570.
11.
Gómez DuqueM, MedinaR, EncisoC, BeltranE, HernandezK, FrancoDM, et al. Usefulness of inhaled sedation in patients with severe ARDS due to COVID-19. Respir Care, 2022; 68(3):293-299.
12.
BlondonnetR, BaldeA, ZhaiR, PereiraB, FutierE, BazinJ-E, et al. Use of volatile anesthetics for sedation in the ICU during the COVID-19 pandemic: a national survey in France (VOL’ICU 2 study). PLoS One, 2022; 17(12):e0278090.
13.
LandoniG, BelloniO, RussoG, BonaccorsoA, CaràG, JabaudonM, et al. Inhaled sedation for invasively ventilated COVID-19 patients: a systematic review. J Clin Med, 2022; 11(9):2500.
14.
MeiserA, VolkT, WallenbornJ, GuentherU, BecherT, BrachtH, et al. Sedaconda study group. Inhaled isoflurane via the anesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomized controlled, non-inferiority trial. Lancet Respir Med, 2021; 9(11):1231-1240.
15.
Müller-WirtzLM, BehneF, KermadA, WagenpfeilG, SchroederM, SesslerDI, et al. Isoflurane promotes early spontaneous breathing in ventilated intensive care patients: a post hoc subgroup analysis of a randomized trial. Acta Anaesthesiol Scand, 2022; 66(3):354-364.
16.
LeeY-M, SongBC, YeumK-J. Impact of volatile anesthetics on oxidative stress and inflammation. Biomed Res Int, 2015; 2015:242709.
17.
O’GaraB, TalmorD. Lung protective properties of the volatile anesthetics. Intensive Care Med, 2016; 42(9):1487-1489.
18.
JabaudonM, BoucherP, ImhoffE, ChabanneR, FaureJ-S, RoszykL, et al. Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study. Am J Respir Crit Care Med, 2017; 195(6):792-800.
19.
KassisEB, BeitlerJR, TalmorD. Lung-protective sedation: moving toward a new paradigm of precision sedation. Intensive Care Med, 2023; 49(1):91-94.
20.
BellgardtM, BombergH, Herzog-NiesceryJ, DaschB, VogelsangH, WeberTP, et al. Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: retrospective analysis. Eur J Anaesthesiol, 2016; 33(1):6-13.
